Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.
Court adviser sides with Illumina in EU row that triggered Grail fine
Dive Brief: Illumina may avoid an approximately 432 million euro fine related to its Grail takeover after an adviser to the Court of Justice of
March 25, 2024